心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

冠心病心绞痛介入前后中医诊疗指南

2018-04-01 中华中医药学会 中国实验方剂学杂志.2018.4

冠心病心绞痛介入治疗中医诊疗

由中华中医药学会心血管病分会委托，通过对2557例经冠脉造影证实的冠心病心绞痛临床病例分析，提取了常见证候要素，在此基础上，研究了202例冠心病心绞痛患者介入前后835例次多个时点的信息， 揭示了冠心病心绞痛介入前后证候演变的规律，形成《冠心病心绞痛介入前后中医诊疗指南》。并经全国范围内的专家多次的探讨和修订，该指南可供中医、中西医结合临床医师使用。

中文标题：

冠心病心绞痛介入前后中医诊疗指南

发布机构：

中华中医药学会

发布日期：

2018-04-01

简要介绍：

由中华中医药学会心血管病分会委托，通过对2557例经冠脉造影证实的冠心病心绞痛临床病例分析，提取了常见证候要素，在此基础上，研究了202例冠心病心绞痛患者介入前后835例次多个时点的信息， 揭示了冠心病心绞痛介入前后证候演变的规律，形成《冠心病心绞痛介入前后中医诊疗指南》。并经全国范围内的专家多次的探讨和修订，该指南可供中医、中西医结合临床医师使用。

 

拓展指南：与冠心病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=冠心病心绞痛介入前后中医诊疗指南)] GetToolGuiderByIdResponse(projectId=1, id=7844e1c0015e81fa, title=冠心病心绞痛介入前后中医诊疗指南, enTitle=, guiderFrom=中国实验方剂学杂志.2018.4, authorId=null, author=, summary=由中华中医药学会心血管病分会委托，通过对2557例经冠脉造影证实的冠心病心绞痛临床病例分析，提取了常见证候要素，在此基础上，研究了202例冠心病心绞痛患者介入前后835例次多个时点的信息， 揭示了冠心病心绞痛介入前后证候演变的规律，形成《冠心病心绞痛介入前后中医诊疗指南》。并经全国范围内的专家多次的探讨和修订，该指南可供中医、中西医结合临床医师使用。 , cover=, journalId=null, articlesId=null, associationId=1618, associationName=中华中医药学会, associationIntro=, copyright=0, guiderPublishedTime=Sun Apr 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>由中华中医药学会心血管病分会委托，通过对2557例经冠脉造影证实的冠心病心绞痛临床病例分析，提取了常见证候要素，在此基础上，研究了202例冠心病心绞痛患者介入前后835例次多个时点的信息， 揭示了冠心病心绞痛介入前后证候演变的规律，形成《冠心病心绞痛介入前后中医诊疗指南》。并经全国范围内的专家多次的探讨和修订，该指南可供中医、中西医结合临床医师使用。 </P> <P> </P>拓展指南：<strong>与<font color=red>冠心病</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=749651c001569069" title="冠心病稳定型心绞痛中医诊疗专家共识" target=_blank>冠心病稳定型心绞痛中医诊疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=69d3d1c0015222d3" title="稳定性冠心病无创影像检查路径的专家共识" target=_blank>稳定性冠心病无创影像检查路径的专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d5a551c001a944d6" title="75岁及以上稳定性冠心病患者运动康复中国家共识" target=_blank>75岁及以上稳定性冠心病患者运动康复中国家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7634b1c001ae62b5" title="冠心病血运重建后心脏性猝死的预防" target=_blank>冠心病血运重建后心脏性猝死的预防</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ca7b21c001a052c5" title="【医生日专题】怎么应对冠心病,或许你该来梅斯指南看看" target=_blank>【医生日专题】怎么应对冠心病,或许你该来梅斯指南看看</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%86%A0%E5%BF%83%E7%97%85" target=_blank>有关冠心病更多指南</a></ul>, tagList=[TagDto(tagId=73149, tagName=冠心病心绞痛), TagDto(tagId=445, tagName=介入治疗), TagDto(tagId=37873, tagName=中医诊疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7796, appHits=439, showAppHits=5, pcHits=6150, showPcHits=1682, likes=135, shares=13, comments=6, approvalStatus=1, publishedTime=Wed Apr 11 22:10:06 CST 2018, publishedTimeString=2018-04-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Apr 11 22:10:06 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 09:58:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=冠心病心绞痛介入前后中医诊疗指南)])
冠心病心绞痛介入前后中医诊疗指南
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1075067, encodeId=224310e50671e, content=很好的文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34386153014, createdName=ms8000000723834244, createdTime=Mon Nov 29 13:34:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075269, encodeId=0f1010e526993, content=不错，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Tue Nov 30 05:51:05 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075066, encodeId=026210e506648, content=很好的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 13:30:16 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918376, encodeId=8b7e9183e6e3, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Wed Jan 20 13:46:52 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309268, encodeId=848e309268b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/19/49c0a6829f2a303032a08579848beb53.jpg, createdBy=d5c22174471, createdName=Lynn3889, createdTime=Thu Apr 26 00:24:32 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2021-11-29 ms8000000723834244

    很好的文章！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1075067, encodeId=224310e50671e, content=很好的文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34386153014, createdName=ms8000000723834244, createdTime=Mon Nov 29 13:34:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075269, encodeId=0f1010e526993, content=不错，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Tue Nov 30 05:51:05 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075066, encodeId=026210e506648, content=很好的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 13:30:16 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918376, encodeId=8b7e9183e6e3, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Wed Jan 20 13:46:52 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309268, encodeId=848e309268b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/19/49c0a6829f2a303032a08579848beb53.jpg, createdBy=d5c22174471, createdName=Lynn3889, createdTime=Thu Apr 26 00:24:32 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2021-11-30 147e4706m08暂无昵称

    不错，谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1075067, encodeId=224310e50671e, content=很好的文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34386153014, createdName=ms8000000723834244, createdTime=Mon Nov 29 13:34:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075269, encodeId=0f1010e526993, content=不错，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Tue Nov 30 05:51:05 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075066, encodeId=026210e506648, content=很好的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 13:30:16 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918376, encodeId=8b7e9183e6e3, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Wed Jan 20 13:46:52 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309268, encodeId=848e309268b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/19/49c0a6829f2a303032a08579848beb53.jpg, createdBy=d5c22174471, createdName=Lynn3889, createdTime=Thu Apr 26 00:24:32 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2021-11-29 黑莓530

    很好的文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1075067, encodeId=224310e50671e, content=很好的文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34386153014, createdName=ms8000000723834244, createdTime=Mon Nov 29 13:34:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075269, encodeId=0f1010e526993, content=不错，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Tue Nov 30 05:51:05 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075066, encodeId=026210e506648, content=很好的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 13:30:16 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918376, encodeId=8b7e9183e6e3, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Wed Jan 20 13:46:52 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309268, encodeId=848e309268b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/19/49c0a6829f2a303032a08579848beb53.jpg, createdBy=d5c22174471, createdName=Lynn3889, createdTime=Thu Apr 26 00:24:32 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2021-01-20 147e4706m08暂无昵称

    学习了，谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1075067, encodeId=224310e50671e, content=很好的文章！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34386153014, createdName=ms8000000723834244, createdTime=Mon Nov 29 13:34:32 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075269, encodeId=0f1010e526993, content=不错，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Tue Nov 30 05:51:05 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075066, encodeId=026210e506648, content=很好的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220118/a9d8887d828e4e5aa6913b151c198a77/5dda65f497734f979445f0322b42e2d0.jpg, createdBy=3b505575469, createdName=黑莓530, createdTime=Mon Nov 29 13:30:16 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918376, encodeId=8b7e9183e6e3, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb355252510, createdName=147e4706m08暂无昵称, createdTime=Wed Jan 20 13:46:52 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=309268, encodeId=848e309268b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/19/49c0a6829f2a303032a08579848beb53.jpg, createdBy=d5c22174471, createdName=Lynn3889, createdTime=Thu Apr 26 00:24:32 CST 2018, time=2018-04-26, status=1, ipAttribution=)]
    2018-04-26 Lynn3889

    谢谢分享

    0